BioWorld

March 31, 2000

View Archived Issues

European Patent Disclosures

Read More

Other News To Note

Read More

Variagenics Files For $100M IPO Following $20M Placement

Read More

Market Conditions Lead Lynx To Withdraw Planned Offering

Read More

Visible Genetics Raises $76M In Follow-On Offering

Read More

Regeneron Raises $77M In Public Offering To Advance Its Programs

Read More

EntreMed To Offer 2M Shares To Boost Three Trials

Read More

Molecular Biosystems In Another Restructuring; 60% Of Staff Cut

Read More

Boston's BIO 2000 Ends With More Than 10,000 Attendees

Read More